Doaa Gamal

Doaa Gamal

Auto-generated profile, based on publicly available information

Doaa Gamal

Microbiology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
DGDoaa Gamal
Doaa Gamal
MFMarta Fernández-Martínez
Marta Fernández-Martínez
DSDalia Salem
Dalia Salem
IEInas El-Defrawy
Inas El-Defrawy
LMLaura Álvarez Montes
Laura Álvarez Montes
LMLuis Martínez Martínez
Luis Martínez Martínez
The aim of this study was to characterize carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates recovered from clinical specimens at a tertiary care hospital in Egypt over a period of 15 months. Eight CRKP isolates were included in this study. The minimum inhibitory concentrations of different antibiotics were determined by broth microdilution and Etest methods. Multilocus sequence typing was performed. Antibiotic resistance genes were assessed by PCR and DNA sequencing. Plasmid analysis was done by S1 nuclease digestion of whole genomic DNA followed by pulsed-field gel electrophoresis (S1-PFGE). Eight carbapenem-resistant NDM-1-producing K. pneumoniae isolates of three different sequence types (ST) were identified (ST147, ST11, and ST17), in which blaNDM-1 was carried by either IncR or untypeable plasmids. Seven out of the eight isolates also contained the rmtF methylase gene. This study describes the occurrence of IncR plasmids carrying blaNDM-1 and rmtF in Egypt, raising concerns regarding this type of replicon and its role in the transmission of these resistance determinants.

25 January 2016 in Emerging Microbes & Infections
Verified
Journal Article
Open access
DGDoaa Gamal
Doaa Gamal
MFMarta Fernández-Martínez
Marta Fernández-Martínez
IEInas Inas El-Defrawy Medical Microbiology Department, Theodor Bilharz Research Institute (TBRI), Cairo 12411, Egypt
Inas Inas El-Defrawy Medical Microbiology Department, Theodor Bilharz Research Institute (TBRI), Cairo 12411, Egypt
ASAlain Alain A Ocampo-Sosa Service of Microbiology, University Hospital Marqués de Valdecilla-IDIVAL, Santander 39008, Spain
Alain Alain A Ocampo-Sosa Service of Microbiology, University Hospital Marqués de Valdecilla-IDIVAL, Santander 39008, Spain
LSLuis Luis Martínez-Martínez Service of Microbiology, University Hospital Marqués de Valdecilla-IDIVAL, Santander 39008, Spain; Department of Molecular Biology, School of Medicine, University of Cantabria, Santander 39008, Spain
Luis Luis Martínez-Martínez Service of Microbiology, University Hospital Marqués de Valdecilla-IDIVAL, Santander 39008, Spain; Department of Molecular Biology, School of Medicine, University of Cantabria, Santander 39008, Spain

1 July 2017 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Open access
AAA. Aguirre-Quiñonero
A. Aguirre-Quiñonero
MCMe Cano
Me Cano
DGD. Gamal
D. Gamal
JCJ. Calvo
J. Calvo
LMLuis Martínez Martínez
Luis Martínez Martínez
The objective of this study was to evaluate the accuracy of the CIM test in the detection of carbapenemase activity in 124 strains of Enterobacteriaceae. A panel of 124 previously characterized Enterobacteriaceae was tested: 77 strains producing the following carbapenemase families: KPC (n = 14), GES (n = 22), NDM (n = 19), VIM (n = 4), IMP (n = 4) and OXA-48 (n = 14) and 47 non-carbapenemase producers. For the CIM method, an active susceptibility meropenem disc was exposed to a bacterial suspension of a test strain; when a carbapenemase is produced, the antibiotic is inactivated allowing uninhibited growth of an indicator strain after overnight incubation. A clear inhibition zone (≥20 mm) was considered indicative of no-carbapenemase activity. All KPC, NDM, VIM, IMP or OXA-48 producing strains were unequivocally detected with the CIM test. CIM false negative results were obtained with eleven Enterobacter cloacae producing GES-6. Two other E. cloacae not producing carbapenemase (one with SHV-12, one hyperproducing AmpC) were positive by the test. The sensitivity and specificity of the assay compared to those of molecular methods were 85.7% and 95.7%, respectively. The CIM method proved to be inexpensive and easy to interpret. It provided less than optimal results in the detection of GES-6 activity.

1 November 2021 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
AEAmira El-Far
Amira El-Far
Safia SamirSafia Samir
Safia Samir
EEEman El-Gebaly
Eman El-Gebaly
MOMaysa Omar
Maysa Omar
HDHeba Dahroug
Heba Dahroug
DGDoaa Gamal
Doaa Gamal
Background: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Pseudomonas aeruginosa are the leading cause of healthcare-associated infections worldwide. Objective: The aim was to identify the resistant phenotypes among P. aeruginosa and to characterize different aminoglycosides and carbapenem resistance genes as major mechanisms of resistance in these isolates, in Theodor Bilharz Research Institute (TBRI), a tertiary care hospital in Cairo, Egypt. Methods: During a period of 11 months, 42 P. aeruginosa clinical isolates were collected from the microbiology laboratory by routine culture. Antimicrobial sensitivity testing to the aminoglycosides gentamicin and amikacin, and other classes of antibiotics, was performed by a disk diffusion method. Isolates were tested for aminoglycoside resistance genes, aac(6ʹ)-lb, aac-(3)-lla, rmtB, rmtC, armA, rmtD, and rmtF, and carbapenemase resistance genes blaNDM, blaVIM, and blaIMP, using conventional PCR. Results: Thirty-three (78.5%) of the clinical P. aeruginosa isolates showed MDR and XDR phenotypes at 42.4% and 57.65%, respectively, and these were included in the study. Aminoglycoside resistance was found in 97%, whereas carbapenem resistance was found in 81% of the isolates phenotypically. Only 59.4% (19/26) of the aminoglycoside-resistant isolates harbored resistance genes; none of the amikacin-susceptible isolates harbored any of the tested aminoglycoside resistance genes. Aminoglycoside resistance genes rmtB, armA, aac(6ʹ)-lb, and rmtF were found at rates of 17/33 (51.5%), 3/33 (9%), 2/33 (6%), and 2/33 (6%), respectively, whereas rmtD, acc(3)-II, and rmtC were not detected. Only 40.7% (11/27) of the carbapenem-resistant isolates harbored resistance genes. Carbapenem resistance genes, blaNDM andblaVIM, were found at rates of 7/33 (21.2%) and 6/33 (18.1%), respectively, and blaIMP was not detected. Conclusion: Rates of MDR and XDR P. aeruginosa and resistance to aminoglycosides and carbapenems in our setting are high. Methyltransferases and metallo-beta-lactamases are the main mechanisms of resistance to aminoglycosides and carbapenems, respectively. The presence of blaNDM and rmtF in the strains confirms their rapid dissemination in the Egyptian environment.

19 April 2022 in Egyptian Journal of Medical Human Genetics
Verified
Journal Article
Open access
PDF file
IEInas El-Defrawy
Inas El-Defrawy
DGDoaa Gamal
Doaa Gamal
RERania El-Gharbawy
Rania El-Gharbawy
EEEman El-Seidi
Eman El-Seidi
EEEhab El-Dabaa
Ehab El-Dabaa
SESomaya Eissa
Somaya Eissa
Background: The irrational use of carbapenems in the last years lead to the emergence of carbapenem-resistant Enterobacteriaceae (CRE). This study aimed at determining the prevalence of CRE intestinal carriage among admitted patients in a tertiary care hospital in Egypt, to characterize carbapenemase-producing genes and to identify possible risk factors of CRE colonization. One hundred rectal swabs were collected from patients within 48 h of hospital admission. Culture was done on chromogenic media and then identification and antibiotic susceptibility testing were done using Vitek 2 compact system. Carbapenemase production was confirmed by Rapidec Carba NP test and by multiplex PCR for blaOXA-48-like, blaNDM-like, blaVIM-like, blaIMP-like and blaKPC-like. Results: A total number of 36 CRE isolates were recovered from 28 patients. Thus, the prevalence of CRE colonization was 28%. Escherichia coli (83%), followed by Klebsiella pneumoniae (17%) were the main species. History of recent hospitalization and prior antibiotic intake were statistically significant risk factors predisposing to CRE colonization. Rapidec Carba NP gave positive results in 29/36 CRE isolates, whereas seven isolates gave negative results; six of them harbored blaOXA-48-like. Overall, the blaOXA-48-like was detected in 24/36 (66.7%), followed by blaNDM-like in 11/36 (30.6%) and lastly blaVIM-like in 1/36 (2.8%). Conclusions: Our findings confirm that CRE colonization is disseminating in our healthcare facility, a fact that should be considered as possible pathogens causing infections in high risk patients. Strict infection control measures should be applied to all CRE carriers at hospital admission and a proper antimicrobial stewardship program should be followed in clinical settings.

1 December 2020 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
DGDoaa Gamal
Doaa Gamal
PEPilar Egea
Pilar Egea
CECristina Elías
Cristina Elías
MFMarta Fernández-Martínez
Marta Fernández-Martínez
MCManuel Causse
Manuel Causse
LMLuis Martínez-Martínez
Luis Martínez-Martínez